Meta-analysis of the performance of ¹⁸F-FDG PET in primary tumor detection in unknown primary tumorsDELGADO-BOLTON, Roberto C; FERNANDEZ-PEREZ, Cristina; GONZALEZ-MATE, Alfredo et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 8, pp 1301-1314, issn 0161-5505, 14 p.Article

Carcinoma of unknown primary (CUP)PAVLIDIS, Nicholas; FIZAZI, Karim.Critical reviews in oncology/hematology. 2009, Vol 69, Num 3, pp 271-278, issn 1040-8428, 8 p.Article

Inflammation as a validated prognostic determinant in carcinoma of unknown primary siteMOHAMED, Z; PINATO, D. J; MAURI, F. A et al.British journal of cancer. 2014, Vol 110, Num 1, pp 208-213, issn 0007-0920, 6 p.Article

Cancer of unknown primary (CUP)PAVLIDIS, Nicholas; FIZAZI, Karim.Critical reviews in oncology/hematology. 2005, Vol 54, Num 3, pp 243-250, issn 1040-8428, 8 p.Article

New Strategies for Carcinoma of Unknown Primary: The Role of Tissue-of-Origin Molecular ProfilingVARADHACHARY, Gauri.Clinical cancer research (Print). 2013, Vol 19, Num 15, pp 4027-4033, issn 1078-0432, 7 p.Article

Cancer from an unknown primary siteDOWELL, Jonathan E.The American journal of the medical sciences. 2003, Vol 326, Num 1, pp 35-46, issn 0002-9629, 12 p.Article

Management of unfavourable carcinoma of unknown primary site: Synthesis of recent literatureYAOVI AMELA, Eric; LAURIDANT-PHILIPPIN, Géraldine; COUSIN, Sophie et al.Critical reviews in oncology/hematology. 2012, Vol 84, Num 2, pp 213-223, issn 1040-8428, 11 p.Article

Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysisLEE, J; HAHN, S; KIM, D.-W et al.British journal of cancer. 2013, Vol 108, Num 1, pp 39-48, issn 0007-0920, 10 p.Article

Overview of Patient Management and Future Directions in Unknown Primary CarcinomaVARADHACHARY, Gauri R; GRECO, F. Anthony.Seminars in oncology. 2009, Vol 36, Num 1, pp 75-80, issn 0093-7754, 6 p.Article

Long-term survivors among patients with cancer of unknown primaryPAVLIDIS, Nicholas; PETRAKIS, Dimitrios; GOLFINOPOULOS, Vassilios et al.Critical reviews in oncology/hematology. 2012, Vol 84, Num 1, pp 85-92, issn 1040-8428, 8 p.Article

Treatment for Patients With Unknown Primary Carcinoma and Unfavorable Prognostic FactorsGRECO, F. Anthony; PAVLIDIS, Nicholas.Seminars in oncology. 2009, Vol 36, Num 1, pp 65-74, issn 0093-7754, 10 p.Article

Irinotecan plus carboplatin for patients with carcinoma of unknown primary siteYONEMORI, K; ADO, M; YAMANAKA, Y et al.British journal of cancer. 2009, Vol 100, Num 1, pp 50-55, issn 0007-0920, 6 p.Article

À la recherche des origines perdues des cancers de primitif inconnu (CAPI) : CUprintMASSARD, Christophe.Bulletin du cancer. 2009, Vol 96, Num 3, pp 253-253, issn 0007-4551, 1 p.Article

Switching benchmarks in cancer of unknown primary : From autopsy to microarrayPENTHEROUDAKIS, George; GOLFINOPOULOS, Vassilios; PAULIDIS, Nicholas et al.European journal of cancer (1990). 2007, Vol 43, Num 14, pp 2026-2036, issn 0959-8049, 11 p.Article

Time trends in survival from cancer of unknown primary: Small steps forwardRIIHIMÄKI, M; HEMMINKI, A; SUNDQUIST, K et al.European journal of cancer (1990). 2013, Vol 49, Num 10, pp 2403-2410, issn 0959-8049, 8 p.Article

Surgical management of unknown primary tumors metastatic to the spine: Clinical articleAIZENBERG, Michele R; FOX, Benjamin D; SUKI, Dima et al.Journal of neurosurgery. Spine. 2012, Vol 16, Num 1, pp 86-92, issn 1547-5654, 7 p.Article

Metastasizing malignant pleomorphic adenoma in a young man : Case reportBOURKE, Jill L; LANGER, Seppo W; JENSEN, Helle L et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2007, Vol 115, Num 7, pp 866-868, issn 0903-4641, 3 p.Article

Individual Life Expectancy Estimation Using Validated Prognostic Scores for Patients with Cancer of Unknown PrimaryFERTE, Charles; PENEL, Nicolas; BONNETERRE, Jacques et al.Oncology. 2010, Vol 78, Num 2, pp 87-93, issn 0030-2414, 7 p.Article

Liver metastases from unknown primary site: demonstration on MR imagesBRAGA, Larissa; SEMELKA, Richard C; DANET, Ioana-Maria et al.Magnetic resonance imaging. 2003, Vol 21, Num 8, pp 871-877, issn 0730-725X, 7 p.Article

A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary siteTSUYA, Asuka; KURATA, Takayasu; FUKUOKA, Masahiro et al.Investigational new drugs. 2013, Vol 31, Num 6, pp 1568-1572, issn 0167-6997, 5 p.Article

ROLE OF DEFINITIVE RADIATION THERAPY IN CARCINOMA OF UNKNOWN PRIMARY IN THE ABDOMEN AND PELVISKELLY, Patrick; DAS, Prajnan; VARADHACHARY, Gauri R et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 5, pp 2012-2017, issn 0360-3016, 6 p.Article

Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapyKODAIRA, M; TAKAHASHI, S; TERUI, Y et al.Annals of oncology. 2010, Vol 21, Num 6, pp 1163-1167, issn 0923-7534, 5 p.Article

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trialGROSS-GOUPIL, M; FOURCADE, A; KAMINSKY, M. C et al.European journal of cancer (1990). 2012, Vol 48, Num 5, pp 721-727, issn 0959-8049, 7 p.Article

Oxaliplatin and Capecitabine in the Treatment of Patients With Recurrent or Refractory Carcinoma of Unknown Primary Site: A Phase 2 Trial of the Sarah Cannon Oncology Research ConsortiumHAINSWORTH, John D; SPIGEL, David R; BURRIS, Howard A et al.Cancer. 2010, Vol 116, Num 10, pp 2448-2454, issn 0008-543X, 7 p.Article

Molecular evidence for a clonal relationship between multiple lesions in patients with unknown primary adenocarcinomaSPEEL, Ernst-Jan M; VAN DE WOUW, Agnes J; CLAESSEN, Sandra M. H et al.International journal of cancer. 2008, Vol 123, Num 6, pp 1292-1300, issn 0020-7136, 9 p.Article